TeraDiscoveries

TeraDiscoveries rapidly discovers novel drugs using cloud computing originally developed at Duke University and first funded by Microsoft.

  • Stage $500K in TTM Revenue
  • Industry Biotechnology
  • Location Durham, NC, USA
  • Currency USD
  • Founded November 2009
  • Employees 12
  • Website teradiscoveries.com

Company Summary

TeraDiscoveries (“TD”) disrupts the global pharmaceutical industry. TD accelerates drug discovery by over 100x using "fancy math to sift through hundreds of millions of molecules to find totally novel drugs that cure diseases." The TD platform, which incorporates the breakthrough awarded the 2013 Nobel Prize in Chemistry, is being applied to the entire human proteome preemptively. We have partnered with and received and investment from Microsoft.

Team

  • Shahar Keinan
    CSO

    A computational chemist by background, Dr. Keinan wrote the underlying drug discovery software while a graduate student at Duke.

  • Ed Addison
    CEO

    www.EdAddison.com

    Twice named entrepreneur of the year, Ed is a serial entrepreneur with three past liquidity events.

  • Lawrence Husick
    CIO

    Chemist, patent attorney and computer hacker, Lawrence has started over nine companies and has taken one public.

  • John McGrath
    Dir Biz Dev

    John manages our joint marketing program with Microsoft.

  • Elizabeth Hobbs
    Computational Biologist

    Ms. Hobbs holds MD degrees in both Molecular Biology and Computer Science.

  • Ken Sorensen
    Financial Advisor

    Dr. Ken Sorensen of Array Capital Management is TeraDiscoveries' financial adviser and board member.

Advisors

  • HutchLaw (pending)
    Lawyer
    Unconfirmed
    TechCFO (pending)
    Accountant
    Unconfirmed

Previous Investors

  • Angels $1M
    Unconfirmed
    Microsoft $1M
    Unconfirmed
    Sweat Equity $1M
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free